NCT02794805View on ClinicalTrials.gov

Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

April 30, 2017

Conditions
Hepatocellular Carcinoma (HCC)
Interventions
DEVICE

¹³C-Octanoate Breath Test

Octanoate Breath Test to be performed on subjects with suspected HCC

Trial Locations (2)

100039

302 Military Hopsital, Beijing

100700

General Hospital of Beijing Military Region, Beijing

Sponsors
All Listed Sponsors
lead

Meridian Bioscience, Inc.

INDUSTRY

NCT02794805 - Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis | Biotech Hunter | Biotech Hunter